DCMM
IMGN

DG Capital Management (Massachusetts)’s Immunogen Inc IMGN Stock Holding History

DG Capital Management (Massachusetts)’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,740
Closed -$160K – 70
2014
Q1 		$160K Buy
+10,740
New +$169K 0.09% 60

Other funds holding IMGN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

DG Capital Management (Massachusetts)'s IMGN Position: Q2 2014 in Review

DG Capital Management (Massachusetts) sold out of Immunogen Inc (IMGN) in Q2 2014, closing a stake of 10,740 shares — an estimated $160K sold.

DG Capital Management (Massachusetts) first reported a position in IMGN in Q1 2014 and held it in 1 quarter. The position peaked at $160K in Q1 2014. 137 funds tracked by Wall St. Rank hold IMGN as of Q2 2014.

  • DG Capital Management (Massachusetts) reported no remaining Immunogen Inc position as of Q2 2014 after selling out during the quarter.
  • DG Capital Management (Massachusetts) sold 10,740 Immunogen Inc shares in Q2 2014, an estimated $160K.
  • DG Capital Management (Massachusetts) first reported a position in Immunogen Inc in Q1 2014 and held it in 1 quarter.
  • DG Capital Management (Massachusetts)'s Immunogen Inc position peaked at $160K in Q1 2014.
  • 137 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2014.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q2 2014, filed 8 Aug 2014.